Skip to main content Start of content

INDU Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting 148
Thursday, February 7, 2019, 8:47 a.m. to 10:30 a.m.
Televised
Presiding
Dan Ruimy, Chair (Liberal)

Liberal

Library of Parliament
• Sarah Lemelin-Bellerose, Analyst
Pharmascience
• David Goodman, Chief Executive Officer
• Alain Boisvert, Head of Government Affairs and Market Access
Consumer Health Products Canada
• Karen Proud, President
• Adam Gibson, Vice-President, Public Affairs
MEDEC
• Brian Lewis, President and Chief Executive Officer
• Diana Johnson, Vice-President, Regulatory Affairs
Chemistry Industry Association of Canada
• Bob Masterson, President and Chief Executive Officer
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Tuesday, January 29, 2019, the Committee resumed its study of the impacts of Canada's regulatory structure on small business.

David Goodman, Karen Proud, Brian Lewis and Bob Masterson made statements and, with Alain Boisvert and Diana Johnson, answered questions.

At 10:30 a.m., the Committee adjourned to the call of the Chair.



Michel Marcotte
Clerk of the Committee